Expanding Healthcare Partnerships Brain+ has established recent collaborations with UK care organizations such as Southcare Homes Group and Age UK, demonstrating emerging opportunities to penetrate the UK caregiving and eldercare markets with digital dementia support solutions.

International Market Development The company's ongoing development of CST-Assistant versions for Germany and participation in EU-funded projects indicate strong potential to expand sales into continental Europe and across the European Union healthcare sectors.

Strategic Leadership Growth Recent high-profile hires, including a Senior Vice President of New Markets and an Advisor with UK health tech expertise, highlight Brain+'s focus on scaling its commercial presence and customizing solutions for new regional markets, creating opportunities for targeted business expansion efforts.

Innovative Non-Drug Therapies As pioneers in digital Cognitive Stimulation Therapy endorsed by health authorities like NICE and the World Alzheimer’s Association, Brain+ is uniquely positioned to approach healthcare providers and insurers seeking evidence-based, non-pharmaceutical dementia care solutions.

Funding and Growth Potential With recent funding of $1.5M and a revenue range of up to $1 million, Brain+ presents opportunities to engage investors and partners interested in early-stage healthtech solutions that are gaining recognition and demonstrating market validation.